Low adherence to the guideline for the acute treatment of migraine

The real-world use of triptans in the treatment of migraine is disappointing. Only 12% of the Danish migraine population purchased a triptan between 2014 and 2019, and only 43% repurchased a triptan after first prescription. The aim of the present study was to assess whether physicians and patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesen, Astrid, Schytz, Henrik Winther, Ostrowski, Sisse Rye, Topholm, Mie, Nielsen, Kaspar, Erikstrup, Christian, Mikkelsen, Susan, Pedersen, Ole Birger, Olesen, Jes, Hansen, Thomas Folkmann, Chalmer, Mona Ameri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120453/
https://www.ncbi.nlm.nih.gov/pubmed/35589944
http://dx.doi.org/10.1038/s41598-022-12545-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120453/
https://www.ncbi.nlm.nih.gov/pubmed/35589944
http://dx.doi.org/10.1038/s41598-022-12545-2

Ejemplares similares